How to buy Tff Pharmaceuticals stock (TFFP)

Tff Pharmaceuticals is a biotechnology business based in the US. Tff Pharmaceuticals shares (TFFP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.07 – the same closing value as a week prior. Tff Pharmaceuticals employs 19 staff and has a trailing 12-month revenue of around $1.2 million.

Our top picks for where to buy Tff Pharmaceuticals stock

Buy Tff Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Tff Pharmaceuticals stock price (NASDAQ: TFFP)

Use our graph to track the performance of TFFP stocks over time.

Tff Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.07
52-week range	$0.06 - $11.00
50-day moving average more info button	$1.27
200-day moving average more info button	$2.51
Wall St. target price	$30.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-5.50

Is it a good time to buy Tff Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tff Pharmaceuticals price performance over time

Historical closes compared with the close of $0.065 from 2024-12-23

1 week (2024-12-18)	0.065
1 month (2024-11-25)	-79.94%
3 months (2024-09-25)	-96.67%
6 months (2024-06-25)	-96.70%

1 year (2023-12-22)	-99.12%
2 years (2022-12-23)	-99.72%
3 years (2021-12-23)	241.25
5 years (2019-12-24)	128.25

Tff Pharmaceuticals financials

Revenue TTM	$1.2 million
Gross profit TTM	$-21,212,704
Return on assets TTM	-105.91%
Return on equity TTM	-213.51%
Profit margin	0%
Book value	$4.04
Market Capitalization more info button	$288,798

TTM: trailing 12 months

Tff Pharmaceuticals share dividends

We're not expecting Tff Pharmaceuticals to pay a dividend over the next 12 months.

Have Tff Pharmaceuticals's shares ever split?

Tff Pharmaceuticals's shares were split on a 1:25 basis on 18 December 2023 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tff Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Tff Pharmaceuticals shares which in turn could have impacted Tff Pharmaceuticals's share price.

Tff Pharmaceuticals share price volatility

Over the last 12 months, Tff Pharmaceuticals's shares have ranged in value from as little as $0.061 up to $11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tff Pharmaceuticals's is 1.316. This would suggest that Tff Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Tff Pharmaceuticals overview

TFF Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Tff Pharmaceuticals is owned by insiders or institutions?
Currently 3.31% of Tff Pharmaceuticals shares are held by insiders and 24.372% by institutions. How many people work for Tff Pharmaceuticals?
Latest data suggests 19 work at Tff Pharmaceuticals. When does the fiscal year end for Tff Pharmaceuticals?
Tff Pharmaceuticals's fiscal year ends in December. Where is Tff Pharmaceuticals based?
Tff Pharmaceuticals's address is: 1751 River Run, Fort Worth, TX, United States, 76107 What is Tff Pharmaceuticals's ISIN number?
Tff Pharmaceuticals's international securities identification number is: US87241J1043 What is Tff Pharmaceuticals's CUSIP number?
Tff Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 87241J104